Efficacy and safety of Axicabtagene ciloleucel (Axi‐cel) for the treatment of relapse/refractory non‐Hodgkin lymphoma: First real‐world data in Chinese population

Author:

Zhao W. L.1,Li Y. H.2,Zou D. H.3,Zhu X. J.4,Ji D. M.5,Qian W. B.6,Lu Y.7,Ji C. Y.8,Zhou K. S.9,Jing H. M.10,Yang H.11,Li L. F.12,Li F.13,Xu K. L.14,Niu T.15,Wu D. P.16,Hu Y.17,Zhao W. L.1

Affiliation:

1. Shanghai Institute of Hematology State Key Laboratory of Medical Genomics National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

2. Department of Hematology Zhujiang Hospital Southern Medical University Guangzhou China

3. State Key Laboratory of Experimental Hematology Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China

4. Department of Hematology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

5. Department of Medical Oncology Fudan University Shanghai Cancer Center Shanghai China

6. Department of Hematology The Second Affiliated Hospital College of Medicine Zhejiang University Hangzhou China

7. Department of Hematology Yinzhou Hospital Affiliated to College of Medicine Ningbo University Ningbo China

8. Department of Hematology Qilu Hospital Cheeloo College of Medicine Shandong University Jinan China

9. Department of Hematology Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital Zhengzhou China

10. Department of Hematology and Lymphoma Research Center Peking University Third Hospital Beijing China

11. Department of Hematology Hongkong University‐Shenzhen Hospital Shenzhen China

12. Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital Tianjin China

13. Department of Hematology The First Affiliated Hospital of Nanchang University Nanchang China

14. Department of Hematology The Affiliated Hospital of Xuzhou Medical University Xuzhou China

15. Department of Hematology West China Hospital Chengdu China

16. Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China

17. Department of Hematology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Axicabtagene Ciloleucel in Large B-Cell Lymphoma;New England Journal of Medicine;2023-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3